Standard Biotools Filter Stocks by Fundamentals

LAB Stock  USD 0.98  0.04  4.26%   
The Price To Book for Standard Biotools is detailed below, including the formula and its most recent reported level. This metric is computed using a widely recognized formula in financial analysis.
=

null

Standard Biotools' Price To Book reflects values from the latest available filings. All figures reflect reported accounting data.

Did You Try This?

Run Portfolio Anywhere Now

   

Portfolio Anywhere

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

Important Fundamentals

Financial Metrics, Fundamentals & Methodology

Fundamental metrics for Standard Biotools are informative when they are tied back to operating resilience and capital allocation. The company is currently operating at a loss. Overall market capitalization tier is small-cap. Standard Biotools financial statements report revenue of 85.33 million, EPS loss of 0.15, negative operating margin of 92.14%, current ratio of 5.87 as of the latest reporting period.

Standard Biotools metrics draw on periodic company reporting and market reference feeds, standardized for cross-period comparison. Reported income, balance-sheet, and cash-flow fields adhere to GAAP or IFRS presentation rules.

Editorial review and methodology oversight provided by: Gabriel Shpitalnik, Member of Macroaxis Editorial Board